Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib

BACKGROUND: There is an urgent need for effective treatments for hepatocellular carcinoma (HCC). Immunotherapy is promising especially when combined with traditional therapies. This study aimed to investigate the immunomodulatory function of an approved Chinese medicine formula, compound kushen inje...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Sun, Mayu, Yao, Wenbo, Wang, Feng, Li, Xiaoguang, Wang, Wei, Li, Jingquan, Gao, Zhihu, Qiu, Lin, You, Rongli, Yang, Chenghua, Ba, Qian, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073790/
https://www.ncbi.nlm.nih.gov/pubmed/32179631
http://dx.doi.org/10.1136/jitc-2019-000317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073790/
https://www.ncbi.nlm.nih.gov/pubmed/32179631
http://dx.doi.org/10.1136/jitc-2019-000317

Ejemplares similares